Financials
- Market Capitalization 438.25 B
- Employee 57 K
- Founded 2012
- CEO Robert A. Michael
- Website www.abbvie.com
- Headquarter Delaware, United States
- FIGI BBG0025Y4RY4
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
96.82
Relación precio/flujo de caja
6.62
Dividendos por acción
6.65
Rendimiento por dividendo, %
2.91
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 10 | LLY Eli Lilly and Company Common Stock | 1184.59 USD | -0.29% | -3.85% | +1.58% | +50.12% | 1.12 T USD | ||
| 17 | JNJ Johnson & Johnson Common Stock | 257.97 USD | +0.37% | -2.58% | +7.48% | +64.54% | 620.99 B USD | ||
| 42 | MRK Merck & Company, Inc. Common Stock | 124.03 USD | +0.39% | -3.77% | +2.08% | +48.68% | 306.33 B USD | ||
| 44 | NVS Novartis AG | 153.39 USD | -0.43% | -2.39% | -0.40% | +27.39% | 292.69 B USD |